apl6 Antibody

Overview of APOL6 Antibody (ab92273)

The APOL6 antibody (ab92273) is a goat polyclonal antibody developed against a synthetic peptide within the human APOL6 amino acid sequence (aa 1–50). Key characteristics include:

• Applications: Validated for Western blot (WB) and immunohistochemistry (paraffin-embedded tissues, IHC-P) .

• Reactivity: Specific to human APOL6 .

• Function: APOL6 is implicated in lipid movement within the cytoplasm and organelle lipid binding, though its precise biological role remains under investigation .

2.1. Target Protein (APOL6)

APOL6 belongs to the apolipoprotein L family, which regulates lipid trafficking and metabolism. Unlike other APOL family members (e.g., APOL1, linked to kidney disease), APOL6’s functional significance is less characterized. Preliminary studies suggest it may influence lipid dynamics in cellular compartments .

2.2. Antibody Performance

• Specificity: Recognizes human APOL6 with no reported cross-reactivity to other APOL isoforms .

• Pathological Relevance: No direct association with thrombotic or autoimmune disorders (e.g., antiphospholipid syndrome) has been established, unlike antibodies targeting β2-glycoprotein I or cardiolipin [1–4,7].

Comparative Analysis of APOL6 vs. Antiphospholipid Antibodies

Limitations and Research Gaps

• Data Scarcity: No peer-reviewed studies directly linking APOL6 antibodies to human diseases were identified in the provided sources.

• Functional Studies: Mechanistic insights into APOL6’s role in lipid regulation or disease are lacking .

• Commercial Availability: Only one supplier (Abcam) currently offers this antibody, limiting independent validation .

Future Directions

• Investigate APOL6’s interaction with lipid pathways using knockout models.

• Explore potential associations with lipid disorders or rare autoimmune conditions.

• Expand antibody validation across diverse sample types (e.g., plasma, cell lines).